T1	Participants 550 774	Adults with a history of reflux symptoms, a negative endoscopy, and > or = 3 days of moderate to very severe heartburn in the 7 days before enrollment (N = 535) entered 4 weeks of open-label, acute treatment with rabeprazole
T2	Participants 793 801	Patients
T3	Participants 1013 1054	patients reported complete symptom relief
T4	Participants 1204 1211	placebo
T5	Participants 1235 1246	rabeprazole
T6	Participants 1300 1339	placebo group vs. the rabeprazole group
